Aquarius Biotechnologies, LLC is founded on a revolutionary drug delivery platform called “cochleates.” When applied to existing drugs, cochleates can address IV administration and toxicity drug delivery issues. The platform 1) creates oral drug alternatives with non-inferior efficacy for drugs that are currently only available via IV and 2) reduces drug toxicity.

Industry Categories

Industry Biomedical
Sub-industry
Focus Areas
Focus Areas - detailed

University

University Rutgers
Scientific Founder Raphael J. Mannino, Ph.D. - Department of Pathology and Laboratory Medicine, New Jersey Medical School

Company

Web http://www.matinasbiopharma.com/
Address
Phone
Fax
Email
SIC
NAICS
DUNS

Markets

Products / Services

Key People

Timeline

  • 2013 – Founded
  • 2015 - Acquired by Matinas BioPharma

Intellectual Property

Patents

Trademarks

Funding

SBIR/STTR

Social Media

LinkedIn Company Page

Facebook Company Page

Twitter

News Feed



No files attached to this page.

Add a New Comment